文献速递心血管技术与安全PETCT

无症状SARS-CoV-2疫苗接种者与未接种者PET/CT心肌18F-FDG摄取评估

Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2-vaccinated and Nonvaccinated Patients.
PubMed 文献 · Radiology · 2023-01-01

本回顾性研究纳入303例未接种者和700例接种者,比较非心肌炎适应症行18F-FDG PET/CT的心肌摄取。接种者总体心肌SUVmax中位数4.8高于未接种者3.3(P<.0001),且不同性别、年龄及接种后1-180天均见升高,同侧腋窝摄取在接种后1-120天也升高。

要点

  • 接种SARS-CoV-2疫苗后1-180天内,无症状患者PET/CT心肌FDG摄取较未接种者升高。
  • 接种者心肌SUVmax中位数4.8,未接种者3.3,差异有统计学意义(P<.0001)。
  • 接种后1-120天同侧腋窝FDG摄取也较未接种者升高。

核心结论

  • 与未接种者相比,无症状患者在第二剂疫苗接种后1-180天行PET/CT显示心肌FDG摄取增高。

研究设计与样本

  • 回顾性研究,纳入303例未接种患者(平均年龄52.9岁±14.9,女性157例)和700例接种患者(平均年龄56.8岁±13.7,女性344例),均为因非心肌炎适应症行18F-FDG PET/CT者。

关键影像表现/征象

  • 接种者总体心肌FDG摄取较未接种者升高(中位SUVmax 4.8 vs 3.3,P<.0001)。
  • 接种后1-30、31-60、61-120、121-180天各亚组心肌SUVmax中位范围4.6-5.1,均高于未接种者。
  • 接种后1-30、31-60、61-120天同侧腋窝SUVmax中位范围1.5-2.0,较未接种者升高(P范围<.001-<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Patients who developed myocarditis following SARS-CoV-2 vaccination show abnormalities on cardiac MRI. However, whether myocardial changes occur in asymptomatic individuals following vaccination is not well established. Purpose To assess myocardial 18Fluorine-fluorodeoxyglucose (18F-FDG) uptake on PET/CT in asymptomatic SARS-CoV-2 vaccinated patients compared to nonvaccinated patients. Materials and Methods This retrospective study included patients who underwent 18F-FDG PET/CT for indications unrelated to myocarditis during the period before (11/1/2020 - 2/16/2021) and after (2/17/20121 - 3/31/2022) SARS-CoV-2 vaccines were available. Myocardial and axillary FDG uptake were quantitatively assessed using maximum standardized uptake value (SUVmax). SUVmax values in all patients and in patients stratified by sex (male/female), age (<40, 41-60, >60 years), and time interval between vaccination and PET/CT were compared using Mann-Whitney U test or Kruskal-Wallis test with post ad -hoc Dwass, Steel, Critchlow-Fligner multiple comparison analysis. Results The study included 303 nonvaccinated patients (mean age, 52.9 years ± 14.9 [SD]; 157 females) and 700 vaccinated patients (mean age, 56.8 years ± 13.7 [SD]; 344 females). Vaccinated patients had overall higher myocardial FDG uptake compared to nonvaccinated patients (median SUVmax, 4.8 [IQR: 3.0-8.5] vs median SUVmax, 3.3 [IQR: 2.5-6.2]; P < .0001). Myocardial SUVmax was higher in vaccinated patients regardless of sex (median range, 4.7-4.9 [IQR: 2.9-8.6]) or patient age (median range, 4.7-5.6 [IQR: 2.9-8.6]) compared to corresponding nonvaccinated groups (sex median range, 3.2-3.9 [IQR: 2.4-7.2]; age median range, 3.3-3.3 [IQR: 2.3-6.1]; P range, <.001-.015). Furthermore, increased myocardial FDG uptake was observed in patients imaged 1-30, 31-60, 61-120, and 121-180 days after their second vaccination (median SUVmax range, 4.6-5.1 [IQR: 2.9-8.6]) and increased ipsilateral axillary uptake was observed in patients imaged 1-30, 31-60, 61-120 days after their 2nd vaccination (median SUVmax range, 1.5-2.0 [IQR: 1.2-3.4]) compared to the nonvaccinated patients (P range, <.001-<.001). Conclusion Compared to nonvaccinated patients, asymptomatic patients who received their 2nd vaccination 1-180 days prior to imaging showed increased myocardial FDG uptake on PET/CT. See also the editorial by Bluemke in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Nakahara T, Iwabuchi Y, Miyazawa R, et al. Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2-vaccinated and Nonvaccinated Patients. Radiology. 2023. PMID: 37724969. doi:10.1148/radiol.230743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。